• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    4/15/24 2:11:35 PM ET
    $ADIL
    $AEYE
    $ATHE
    $BB
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ADIL alert in real time by email

    Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

    Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Soligenix, Inc. (NASDAQ:SNGX) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.
    • Longeveron Inc. (NASDAQ:LGVN) surged 54% to $2.6350 following insider buys from multiple company executives.
    • SuperCom Ltd. (NASDAQ:SPCB) shares gained 39.4% to $0.3849 after jumping around 18% on Friday.
    • Piedmont Lithium Inc. (NYSE:PLL) shares gained 32.1% to $16.75 following a 5% decline on Friday.
    • Snap One Holdings Corp. (NASDAQ:SNPO) surged 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies.
    • Organovo Holdings, Inc. (NASDAQ:ONVO) shares surged 30.9% to $1.32 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo.
    • Kuke Music Holding Limited (NASDAQ:KUKE) jumped 27% to $2.7650.
    • HUB Cyber Security Ltd. (NASDAQ:HUBC) gained 24% to $1.61 after gaining over 11% on Friday.
    • Edgio, Inc. (NASDAQ:EGIO) gained 24% to $22.18.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) surged 23.6% to $3.30.
    • Envoy Medical, Inc. (NASDAQ:COCH) gained 22.6% to $6.19.
    • Medical Properties Trust, Inc. (NYSE:MPW) rose 19.9% to $4.7850 after the company announced that it sold its majority interest in Utah Hospitals.
    • CareMax, Inc. (NASDAQ:CMAX) climbed 19.5% to $3.78.
    • SES AI Corporation (NYSE:SES) surged 18.7% to $1.77.
    • Mobile-health Network Solutions (NASDAQ:MNDR) gained 17.7% to $17.67.
    • Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) rose 16.7% to $2.72.
    • ProKidney Corp. (NASDAQ:PROK) gained 16.7% to $2.0426.
    • Biotricity, Inc. (NASDAQ:BTCY) rose 16.5% to $1.34.
    • Yatsen Holding Limited (NYSE:YSG) gained 13.3% to $3.41.
    • Destiny Tech100 Inc. (NASDAQ:DXYZ) shares gained 12.8% to $32.71 after dipping 42% on Friday.
    • Encore Wire Corporation (NASDAQ:WIRE) surged 11.7% to $291.60 after the company entered an agreement to be acquired by Prysmian for $290 per share in cash.
    • Century Aluminum Company (NASDAQ:CENX) gained 9.5% to $18.05.
    • Extreme Networks, Inc. (NASDAQ:EXTR) gained 5.7% to $11.31. B. Riley Securities analyst Dave Kang upgraded Extreme Networks from Neutral to Buy and maintained a $14 price target.

    Losers

    • Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shares dipped 77% to $1.6800 after the company provided an update on the Phase 3 RAISE trial and reported preliminary Q1 financial results.
    • Swvl Holdings Corp. (NASDAQ:SWVL) fell 35% to $8.58.
    • VIA optronics AG (NASDAQ:VIAO) dipped 34% to $0.2765.
    • Veru Inc. (NASDAQ:VERU) fell 24% to $1.1550. Oppenheimer analyst Leland Gershell reiterated Veru with an Outperform and lowered the price target from $7 to $5.
    • Rent the Runway, Inc. (NASDAQ:RENT) dipped 19.8% to $15.42.
    • NextPlat Corp (NASDAQ:NXPL) fell 19.8% to $1.50 after jumping 24% on Friday. The company entered into a definitive business combination agreement with its majority-owned subsidiary Progressive Care Inc.
    • Cyngn Inc (NASDAQ:CYN) shares fell 19.1% to $0.1170 after declining around 7% on Friday.
    • ProMIS Neurosciences, Inc. (NASDAQ:PMN) fell 15.6% to $1.95.
    • Biohaven Ltd. (NASDAQ:BHVN) dipped 15.4% to $44.90. Biohaven showcased innovative neuroscience portfolio with 20 presentations at the 2024 AAN Annual Meeting.
    • Neumora Therapeutics, Inc. (NASDAQ:NMRA) shares declined 15.1% to $11.48 after the FDA placed a clinical hold on the company's Phase 1 NMRA-266 study.
    • Alterity Therapeutics Limited (NASDAQ:ATHE) dipped 15% to $2.49.
    • Surf Air Mobility Inc. (NASDAQ:SRFM) fell 15% to $0.53.
    • IM Cannabis Corp (NASDAQ:IMCC) fell 14.2% to $0.5399.
    • Polestar Automotive Holding Uk Plc (NASDAQ:PSNY) fell 12.7% to $1.2699. On Friday, Cantor Fitzgerald analyst Andres Sheppard reiterated Polestar Automotive with an Overweight and maintained a $5 price target.
    • Desktop Metal, Inc. (NYSE:DM) fell 10.8% to $0.8510.
    • Local Bounti Corporation (NYSE:LOCL) declined 10.2% to $2.1550.
    • Q32 Bio Inc. (NASDAQ:QTTB) fell 10% to $26.00.
    • SunPower Corporation (NASDAQ:SPWR) fell 8.3% to $2.2750.
    • Informatica Inc. (NASDAQ:INFA) dipped 8.1% to $35.36 amid increased volatility following reports suggesting Salesforce is in talks to buy the company.
    • TRACON Pharmaceuticals Inc (NASDAQ:TCON) declined 8.1% to $2.1699 after falling around 9% on Friday.
    • NOVONIX Limited (NYSE:NVX) declined 7.2% to $2.63.
    • AudioEye, Inc. (NASDAQ:AEYE) fell 6.6% to $12.86 after declining around 7% on Friday.
    • OncoCyte Corp (NASDAQ:OCX) fell 6.6% to $2.5301. Oncocyte announced a transplant assay partnership agreement with Bio-Rad laboratories.
    • BlackBerry Limited (NYSE:BB) fell 6.1% to $2.8650.

     

    Now Read This: Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings

    Get the next $ADIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADIL
    $AEYE
    $ATHE
    $BB

    CompanyDatePrice TargetRatingAnalyst
    Biohaven Ltd.
    $BHVN
    4/13/2026$21.00Buy
    Canaccord Genuity
    Envoy Medical Inc.
    $COCH
    3/31/2026$2.50Buy
    H.C. Wainwright
    Ultragenyx Pharmaceutical Inc.
    $RARE
    3/24/2026$25.00Buy → Neutral
    Goldman
    Polestar Automotive Holding UK PLC
    $PSNY
    2/19/2026Neutral → Underweight
    Cantor Fitzgerald
    Neumora Therapeutics Inc.
    $NMRA
    2/17/2026Mkt Perform → Outperform
    William Blair
    Biohaven Ltd.
    $BHVN
    2/6/2026$23.00Buy
    Goldman
    Biohaven Ltd.
    $BHVN
    1/21/2026$22.00Sector Perform → Outperform
    RBC Capital Mkts
    Neumora Therapeutics Inc.
    $NMRA
    1/12/2026$8.00Outperform
    Leerink Partners
    More analyst ratings

    $ADIL
    $AEYE
    $ATHE
    $BB
    SEC Filings

    View All

    Longeveron Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Longeveron Inc. (0001721484) (Filer)

    4/10/26 4:49:03 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by IM Cannabis Corp.

    6-K - IM Cannabis Corp. (0001792030) (Filer)

    4/10/26 4:30:07 PM ET
    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form S-1 filed by Longeveron Inc.

    S-1 - Longeveron Inc. (0001721484) (Filer)

    4/10/26 4:01:48 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AEYE
    $ATHE
    $BB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF FINANCIAL OFFICER Georgevich Kelly bought $99,398 worth of shares (16,850 units at $5.90), increasing direct ownership by 13% to 144,981 units (SEC Form 4)

    4 - AUDIOEYE INC (0001362190) (Issuer)

    3/17/26 4:35:45 PM ET
    $AEYE
    Computer Software: Prepackaged Software
    Technology

    Director Hawkins James B bought $219,744 worth of shares (38,000 units at $5.78), increasing direct ownership by 22% to 207,517 units (SEC Form 4)

    4 - AUDIOEYE INC (0001362190) (Issuer)

    3/12/26 4:20:55 PM ET
    $AEYE
    Computer Software: Prepackaged Software
    Technology

    Amendment: Director Childs John W bought $864,115 worth of shares (28,400 units at $30.43) (SEC Form 4)

    4/A - Biohaven Ltd. (0001935979) (Issuer)

    3/9/26 6:12:05 PM ET
    $BHVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AEYE
    $ATHE
    $BB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AEYE
    $ATHE
    $BB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IMC Announces Receipt of Nasdaq Minimum Bid Price Notification

    TORONTO and GLIL YAM, Israel, April 10, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has received a written notice (the "Notice") from Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a period of 180 calendar days to regain compliance with the minimum bid price requirement. The N

    4/10/26 4:10:00 PM ET
    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care

    Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells

    AVAI, LCTX, OCGN, VRTX, and LGVN Advance Cell-Based and Gene-Therapy Approaches to Age-Related DiseaseIssued on behalf of Avaí Bio, Inc.Companies mentioned in this article: Avaí Bio, Inc. (OTCQB:AVAI), Lineage Cell Therapeutics, Inc. (NYSE:LCTX), Ocugen, Inc. (NASDAQ:OCGN), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Longeveron Inc. (NASDAQ:LGVN)Key Takeaways:Avaí Bio (OTCQB:AVAI) and its joint venture partner Austrianova announced on April 7, 2026, that they will present their latest data from their α-Klotho anti-aging therapy at the Second Annual Klotho Conference in September, alongside Dr. Makoto Kuro-o — the physician-scientist widely recognized for discovering the Klotho gene [1

    4/10/26 9:55:00 AM ET
    $LCTX
    $LGVN
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    NOVONIX US$103 Million 48C Tax Credits Certified for Synthetic Graphite Facility

    CHATTANOOGA, Tenn., April 09, 2026 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ:NVX, ASX: NVX)) ("NOVONIX" or the "Company"), a leading battery materials company, today announced that the U.S. Government has certified its Riverside project in connection with the US$103 million in tax credits previously allocated under the U.S. Government's Section 48C Advanced Energy Project Credit Program. "This certification from the Trump administration is the latest vote of confidence in a mission that has always been bigger than politics. I'm proud that building America's critical mineral supply chain begins right here at home, in Chattanooga, Tennessee." – U.S. Representative Chuck Fleischmann. This d

    4/9/26 6:24:51 PM ET
    $NVX
    Industrial Machinery/Components
    Miscellaneous

    $ADIL
    $AEYE
    $ATHE
    $BB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rodgers Thurman J

    4 - SunPower Inc. (0001838987) (Issuer)

    4/10/26 5:30:02 PM ET
    $SPWR
    Semiconductors
    Technology

    SEC Form 3 filed by new insider Gozlan Lawrence Bernard

    3 - ALTERITY THERAPEUTICS LTD (0001131343) (Issuer)

    4/10/26 8:21:34 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Babarczy Julian Michael

    3 - ALTERITY THERAPEUTICS LTD (0001131343) (Issuer)

    4/10/26 8:16:54 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AEYE
    $ATHE
    $BB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Biohaven with a new price target

    Canaccord Genuity initiated coverage of Biohaven with a rating of Buy and set a new price target of $21.00

    4/13/26 8:51:07 AM ET
    $BHVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    H.C. Wainwright initiated coverage on Envoy Medical with a new price target

    H.C. Wainwright initiated coverage of Envoy Medical with a rating of Buy and set a new price target of $2.50

    3/31/26 8:12:03 AM ET
    $COCH
    Industrial Specialties
    Health Care

    Ultragenyx Pharma downgraded by Goldman with a new price target

    Goldman downgraded Ultragenyx Pharma from Buy to Neutral and set a new price target of $25.00

    3/24/26 8:28:47 AM ET
    $RARE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $AEYE
    $ATHE
    $BB
    Leadership Updates

    Live Leadership Updates

    View All

    HUB Cyber Security Announces Leadership Transition

    TEL AVIV, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (NASDAQ:HUBC) ("HUB" or the "Company"), announced that Noah Hershcoviz has resigned from his position as Chief Executive Officer and as a member of the Company's Board of Directors (the "Board"), effective immediately. Renah Persofsky, the Active Chairperson of the Board, will take on a greater role in the management of the Company, while the Company seeks to find a suitable interim replacement for Mr. Hershcoviz, which it hopes to announce shortly. The Company intends to commence a search for qualified candidates to serve as a new permanent CEO in the coming days.       "The Board of Directors appreciates Noah's

    3/31/26 4:30:00 PM ET
    $HUBC
    Computer Communications Equipment
    Telecommunications

    ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer

    WINSTON-SALEM, N.C., March 25, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today announced the appointment of Greg Madison as Chief Commercial Officer. In this role, Mr. Madison will drive ProKidney's commercial strategy as the Company advances towards the potential commercialization of rilparencel. "Greg is a seasoned commercial biopharma executive with a proven track record of building high-performing organizations, shaping strategy, and preparing innovative therapies for market," said Bruce Culleton, M.D., CEO of ProKidney. "He brings valuable operation

    3/25/26 4:01:00 PM ET
    $PROK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    $ADIL
    $AEYE
    $ATHE
    $BB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Oncocyte Corporation

    SC 13G/A - Oncocyte Corp (0001642380) (Subject)

    12/9/24 5:30:06 PM ET
    $OCX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13D/A filed by Neumora Therapeutics Inc.

    SC 13D/A - Neumora Therapeutics, Inc. (0001885522) (Subject)

    11/22/24 5:33:43 PM ET
    $NMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADIL
    $AEYE
    $ATHE
    $BB
    Financials

    Live finance-specific insights

    View All

    Extreme Networks Schedules Third Quarter 2026 Financial Results Conference Call

    Extreme Networks, Inc. (NASDAQ:EXTR), a leader in AI-powered automation for networking, today announced plans to release financial results for its third fiscal quarter 2026, ended March 31, 2026. The company will announce before market open on Wednesday, April 29, 2026, followed by an earnings conference call and webcast at 8:00 a.m. ET. The details for the webcast are: When:     Wednesday, April 29, 2026 at 8:00 a.m. ET (5:00 a.m. PT)   Where: https://investor.extremenetworks.com   Dial in/ webcast: To access the call by phone or webcast, please go to this link (Registration Link) and you will be provided with dial-in details

    4/7/26 4:05:00 PM ET
    $EXTR
    Computer Communications Equipment
    Telecommunications

    SES AI Provides First Quarter 2026 Business Update

    Expects first quarter 2026 revenue of $6.3 million to $6.5 million Affirms full year 2026 revenue guidance of $30 million to $35 million Plans to report first quarter 2026 results on April 23, 2026 SES AI Corporation ("SES AI", the "Company," "we" or "us") (NYSE:SES), a global leader in the development and manufacturing of AI-enhanced high-performance Li-Metal and Li-ion batteries, today provided a business update for the first quarter of 2026, including expected revenue for the quarter and affirmed its previously issued full year 2026 revenue guidance. First Quarter 2026 Business Update Based on preliminary results, the Company expects first quarter 2026 revenue to be in the rang

    4/1/26 7:00:00 AM ET
    $SES
    Industrial Machinery/Components
    Miscellaneous

    NextPlat Reports $54 Million in Revenue for Full Year 2025 as Business Turnaround Initiatives Support Operational Profitability Goals in 2026

    Refocusing and Cost Cutting Efforts Now Delivering Operational Improvement Including Sequential Margin Expansion and Significant Cost ReductionsHALLANDALE BEACH, Fla., March 31, 2026 /PRNewswire/ -- NextPlat Corp (NASDAQ:NXPL, NXPLW)) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced the financial results for the year ended December 31, 2025, reflecting the performance of its healthcare and e-commerce operations. "The closing of 2025 marks

    3/31/26 8:01:00 AM ET
    $NXPL
    Telecommunications Equipment
    Telecommunications